Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kuestner
Natalie Kuestner, Stuttgart DE
| Patent application number | Description | Published |
|---|---|---|
| 20100050612 | PROCEDURE AND DEVICE FOR THE INCREASE IN VALUE OF ONE DOSE ARRANGEMENT - The invention concerns a procedure for controlling a metering device for metering fuel into the exhaust gas duct of a combustion engine for the regeneration of a particle filter, whereby the metering device supplies the fuel to the exhaust gas duct over a security valve, a first fuel pipe, a metering valve, a second fuel pipe and an injection check valve and whereby the pressure of the fuel is determined between the metering valve and the injection check valve in the second fuel pipe. It is thereby provided that an opening pressure of the injection check valve is determined from the pressure course between the metering valve and the injection check valve. | 03-04-2010 |
Oliver Kuestner, Brackenheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20110060668 | SYSTEM AND METHOD FOR GENERATING A COMBINED STATEMENT - A combined statement processing (“CSP”) system and method provides a combined statement attribute to a master contract, which defines a set of accounts for which a combined statement should be generated. The CSP may generate a number of unique tokens passed on a pre-existing output management system (“OMS”). The unique tokens may also be passed to a set of account management systems (“AMS”), which may trigger various reports to the OMS by the AMSs. Using the unique tokens sent by the CSP, the OMS may then hold the output production until reporting data is received by the AMSs from each unique token. This way, a pre-existing OMS and pre-existing AMSs may be leveraged to with little or no alteration to generate a combined statement. | 03-10-2011 |
Rolf E. Kuestner, Bothell, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080213831 | HUMAN CYTOKINE RECEPTOR - Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor18.” | 09-04-2008 |
| 20090192292 | MURINE ZCYTOR17 LIGAND POLYPEPTIDES AND POLYNUCLEOTIDES - The present invention relates to zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules. The zcytor17lig is a novel cytokine. The polypeptides may be used within methods for stimulating the immune system, and proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto. | 07-30-2009 |
| 20100113748 | SOLUBLE IL-17RCX4 AND METHODS OF USING IN INFLAMMATION - The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17F, IL-17A, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. IL-17RC is a common receptor for IL-17A and IL-17F. The present invention includes methods of using a soluble IL-17RC receptor, IL-17RCx4 for treating inflammation. | 05-06-2010 |